Ameritas Advisory Services’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-5
Closed -$622 – 2757
2025
Q2
$622 Buy
+5
New +$636 ﹤0.01% 2681
2023
Q2
– Sell
-58
Closed -$9.76K – 2097
2023
Q1
$9.76K Buy
+58
New +$10.3K ﹤0.01% 1904

Other funds holding RGEN

Ameritas Advisory Services's RGEN Position: Q3 2025 in Review

Ameritas Advisory Services sold out of Repligen (RGEN) in Q3 2025, closing a stake of 5 shares — an estimated $622 sold.

Ameritas Advisory Services first reported a position in RGEN in Q1 2023 and held it in 2 quarters. The position peaked at $9.76K in Q1 2023. 453 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.

  • Ameritas Advisory Services reported no remaining Repligen position as of Q3 2025 after selling out during the quarter.
  • Ameritas Advisory Services sold 5 Repligen shares in Q3 2025, an estimated $622.
  • Ameritas Advisory Services first reported a position in Repligen in Q1 2023 and held it in 2 quarters.
  • Ameritas Advisory Services's Repligen position peaked at $9.76K in Q1 2023.
  • 453 funds tracked by Wall St. Rank held Repligen as of Q3 2025.

Based on Ameritas Advisory Services's 13F filing for Q3 2025, filed 6 Nov 2025.